| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 35151 |
| 1 | METHOTREXATE SODIUM | 26218 |
| 2 | METHOTREXATE | 23673 |
| 3 | ADALIMUMAB | 21366 |
| 4 | LEFLUNOMIDE | 13904 |
| 5 | PREDNISONE | 12418 |
| 6 | ABATACEPT | 12193 |
| 7 | TOCILIZUMAB | 11518 |
| 8 | HYDROXYCHLOROQUINE SULFATE | 11163 |
| 9 | SULFASALAZINE | 9443 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 88 | 0.8148 |
| 1 | GOLD | 1551 | 0.4858 |
| 2 | DESOXIMETASONE | 1156 | 0.2620 |
| 3 | SODIUM BORATE | 10 | 0.2500 |
| 4 | CORTISONE ACETATE | 717 | 0.2278 |
| 5 | PHOSPHORIC ACID | 16 | 0.2105 |
| 6 | LEFLUNOMIDE | 13904 | 0.2070 |
| 7 | SULFASALAZINE | 9443 | 0.2055 |
| 8 | TOCILIZUMAB | 11518 | 0.2047 |
| 9 | PSEUDOEPHEDRINE HCL | 486 | 0.1966 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 39039 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 23474 |
| 2 | Corticosteroid [EPC] | 15631 |
| 3 | Antirheumatic Agent [EPC] | 13913 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12748 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 12193 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 11924 |
| 7 | Aminosalicylate [EPC] | 9517 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 8858 |
| 9 | Vitamin C [EPC] | 7806 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 13913 | 0.2055 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 11924 | 0.1957 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 12193 | 0.1596 |
| 3 | Aminosalicylate [EPC] | 9517 | 0.1281 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 1006 | 0.1167 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 23474 | 0.0842 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 8858 | 0.0714 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 39039 | 0.0536 |
| 8 | Prostaglandin E1 Analog [EPC] | 675 | 0.0506 |
| 9 | Vitamin D [EPC] | 7771 | 0.0465 |